The world has yet to see a form of the deadly bird flu virus that could spread easily between people and cause a global outbreak - but that doesn't mean it won't happen, scientists said on Thursday.
After studying 15 years of data on bird flu viruses in the wild, researchers said some strains were already part way along the road to acquiring a handful of mutations needed to change into a form that could cause a devastating human pandemic.
"The remaining... mutations could evolve in a single human host, making a virus evolving in nature a potentially serious threat," Derek Smith of Britain's University of Cambridge, who led the research, told reporters.
Currently, bird flu, or H5N1 avian flu, can be transmitted from birds to birds, and birds to humans, but not from humans to humans. When it does pass from birds to humans, it is usually fatal.
Two earlier studies by researchers in the United States and Europe have found that with as few as five mutations, H5N1 flu can become transmissible in the air between mammals, including potentially from person to person.
Their work was highly controversial because they manipulated viruses in the lab to produce the new mutated strains.
Mutations are already out there
Until now, scientists were not sure whether it was possible these same mutations could evolve in nature.
But Smith's co-researcher Colin Russell said their study, published on Thursday in the journal Science, showed it was.
"Viruses that have two of these mutations are already common in birds, meaning that there are viruses that might have to acquire only three additional mutations in a human to become airborne transmissible," he told reporters.
So far, the H5N1 virus, which was first detected in Hong Kong in 1997, has infected tens of millions of ducks, geese, chickens and other birds. People who have been infected - so far there have been 606, of whom 357 have died - are mostly those who came into close contact with birds.
Last year, teams led by Ron Fouchier at Erasmus Medical Center and by Yoshihiro Kawaoka at the University of Wisconsin managed to create laboratory-enhanced versions of the virus that spread like ordinary flu between mammals.
This type of research is seen as vital for scientists working to develop vaccines, diagnostic tests and anti-viral drugs that could be deployed in the event of an H5N1 pandemic.
But opponents said the work could be misused by terrorists or that the virus might somehow escape from the lab and spread. An international row over the publication of the two papers blew up, leading to a temporary moratorium on such research.
"Active fault line"
Smith likened scientists' current position on the likelihood of an H5N1 human pandemic to that of researchers trying to predict an earthquake.
"We now know that we're living on a fault line," he said. "And what we have discovered in this working collaboration with Fouchier and Kawaoka is that it's an active fault line. It really could do something. We've seen no fundamental hurdle to that happening."
But he said it was impossible to assess the exact risk. "We know it is in the realms of possibility ... and what needs to be done now is to assess the risk more accurately."
In a second H5N1 study published as part of a series on bird flu in Science on Thursday, Rino Rappuoli, a researcher at the Swiss drugmaker Novartis's vaccines and diagnostics unit in Italy, outlined how the world could better prepare for a potential bird flu pandemic.
Among the most important steps, he said, would be to immunise as many people as possible with existing H5N1 vaccines to prime their immune systems and reduce the severity of illness if a pandemic were to happen. There was also a need to ensure manufacturers could make large quantities of a pandemic vaccine quickly by sharing strains and scientific knowledge swiftly across the world.
Located in the bustling Adjame quarter of Ivory Coast's main city and commercial hub, the haven for fake medicine has been targeted time and again by authorities and stockpiles burnt.
Seven firms to receive ecolabel certifying that their products are environment-friendly
Disasters saddle U.S. with $306 billion price tag, cause 362 deaths
Association for Prevention of Drug Abuse head says close to more than 2.5 million children are drug addicts in Bangladesh
King penguins are certainly accustomed to chilly weather, more so than species like the Humboldt that prefer somewhat warmer climes, said zoo curator Malu Celli.
Some eight million children and teenagers across the Southeast Asian nation will receive the shot to prevent further spread of the disease which is caused by a bacterial infection.
Two players vomited on the pitch, and play had to be halted briefly.
French pharmaceutical giant Sanofi announced Wednesday that its world-first dengue vaccine could lead to more severe symptoms for people who had not previously been infected.
Doctors Worldwide Turkey says it has performed 3,000 cataract surgeries in Horn of Africa country
Over 40,000 cases of cholera seen in Democratic Republic of Congo since July, says Health Ministry
Decked out in red to signify their "Stop Coal" campaign, the protesters chanted and beat drums as they snaked through the former West Germany capital toward the UN centre that will host the 12-day, 196-nation talks, tasked with implementing the landmark Paris Agreement.
The Greenhouse Gas Bulletin, the UN weather agency's annual flagship report, tracks the continent of dangerous gasses in atmosphere in the post-industrial era (since 1750).
£10 ($13) tax introduced to cut British capital's poor air-pollution records
Despite all-out efforts to give the Chinese Communist Party blue skies for its twice-a-decade congress, Beijing's notorious smog has cloaked the mega-city in its trademark toxic haze.
Equipment donation to children's oncology institute is first project of state-run aid agency TIKA in Brazil
Some 450 other suspected cases seen in island nation; president says health workers are able to contain epidemic